Sirolimus Conversion Regimen Versus Continued Calcineurin Inhibitors in Liver Allograft Recipients: A Randomized Trial
Open Access
- 10 January 2012
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 12 (3) , 694-705
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Immunosuppressive Switch to Sirolimus in Renal Dysfunction After Liver TransplantationTransplantation Proceedings, 2009
- Sirolimus Monotherapy Effectiveness in Liver Transplant Recipients With Renal Dysfunction Due to Calcineurin InhibitorsJournal of Clinical Gastroenterology, 2009
- Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT TrialTransplantation, 2009
- Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimusLiver Transplantation, 2003
- Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipientsLiver Transplantation, 2003
- Calcineurin inhibitor‐induced chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agentClinical Transplantation, 2002
- Sirolimus-based immunosuppresive protocol for calcineurin sparing in liver transplantationTransplantation Proceedings, 2002
- END-STAGE RENAL DISEASE (ESRD) AFTER ORTHOTOPIC LIVER TRANSPLANTATION (OLTX) USING CALCINEURIN-BASED IMMUNOTHERAPY1Transplantation, 2001
- Renal Insufficiency and Hypertension as Long-Term Complications in Liver TransplantationSeminars in Liver Disease, 1995
- Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patientsTransplant International, 1994